Eligibility Criteria:
Inclusion Criteria:
* Having a single and live baby between 37-42 weeks of gestation,
* Normal spontaneous vaginal delivery,
* Multiparous,
* Having a baby weighing 2-4 kilograms,
* No general anesthetic agent was used at birth,
* Have not used a non-pharmacological method for pain before,
* Having a Visual Analogue Scale (VAS) score of 4 and above for uterine pain before breastfeeding,
* Not having breastfeeding problems,
* Not having any health problems (Tuberculosis, HIV, cancer, etc.),
* Having given birth at least 6 hours ago,
* Does not have any problems preventing communication,
* Able to read and write,
* Able to speak and understand Turkish,
* Volunteer mothers who agreed to participate in the study will be included.
Exclusion Criteria:
* Having a situation that prevents breastfeeding (galactosemia, congenital anomalies, etc.),
* Having postpartum complications (bleeding, infection, etc.),
* Separated from her baby for any reason after birth (in cases where the mother or baby is referred, hospitalized in intensive care or isolated),
* Having lost her baby,
* Having any complications during pregnancy (gestational diabetes, preeclampsia, Rh incompatibility, heart disease, etc.),
* With uterine anomaly,
* Tissue integrity deteriorated in the area to be treated,
* Taking painkillers in the last 6 hours,
* Smoking or using alcohol,
* Those with positive Covid-19 test will be excluded from the study. In addition, those who want to leave the research at any stage of the research will be excluded from the research.